Comparison of Umbelliprenin and Auraptene in Cytotoxic Effects and Myeloid Cell Leukaemia Type-1 (Mcl-1) Gene Expression

被引:12
|
作者
Motlagh, F. Movahedi [1 ]
Gholami, O. [2 ]
机构
[1] Sabzevar Univ Med Sci, Cellular & Mol Res Ctr, Sabzevar, Iran
[2] Sabzevar Univ Med Sci, Fac Med, Dept Physiol & Pharmacol, Sabzevar, Iran
关键词
Umbelliprenin; auraptene; cytotoxicity; apoptosis; myeloid cell leukaemia type 1; CANCER CELLS; COUMARIN; APOPTOSIS; THERAPY; INHIBITION;
D O I
10.4172/pharmaceutical-sciences.1000189
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Induction of apoptosis in tumour cells is one of the mechanisms of chemotherapy. Myeloid cell leukaemia type 1 is one of the Bcl-2 protein families that make an important role in chemo-resistance to drugs. Thus, down-regulation of myeloid cell leukaemia type 1 gene is one of the aims in chemotherapy. Umbelliprenin and auraptene are naturally occurring coumarins, which exhibit cytotoxic and apoptosis inducing capabilities. In this study, we compared the cytotoxicity of these two coumarins against some cancer cell lines by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay method. In the next step, we tested the effect of auraptene on myeloid cell leukaemia type 1 gene expression in Jurkat cells by real time polymerase chain reaction method. We found that umbelliprenin and auraptene possessed cytotoxic effect against the tested cancer cell lines. Auraptene is more cytotoxic than umbelliprenin. We also found that auraptene down-regulated myeloid cell leukaemia type 1 gene expression in a pattern that was different from umbelliprenin.
引用
收藏
页码:827 / 833
页数:7
相关论文
共 50 条
  • [31] Engineering a CRISPRoff Platform to Modulate Expression of Myeloid Cell Leukemia (MCL-1) in Committed Oligodendrocyte Neural Precursor Cells
    Gil, Melanie
    Hamann, Catherine A.
    Brunger, Jonathan M.
    Gama, Vivian
    BIO-PROTOCOL, 2024, 14 (01):
  • [32] Increased MCL-1 expression predicts poor prognosis and disease recurrence in acute myeloid leukemia
    Li, Xi-xi
    Zhou, Jing-dong
    Wen, Xiang-mei
    Zhang, Ting-juan
    Wu, De-hong
    Deng, Zhao-qun
    Zhang, Zhi-hui
    Lian, Xin-yue
    He, Pin-fang
    Yao, Xin-yu
    Lin, Jiang
    Qian, Jun
    ONCOTARGETS AND THERAPY, 2019, 12 : 3295 - 3304
  • [33] Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells
    De Veirman, Kim
    Van Ginderachter, Jo A.
    Lub, Susanne
    De Beule, Nathan
    Thielemans, Kris
    Bautmans, Ivan
    Oyajobi, Babatunde O.
    De Bruyne, Elke
    Menu, Eline
    Lemaire, Miguel
    Van Riet, Ivan
    Vanderkerken, Karin
    Van Valckenborgh, Els
    ONCOTARGET, 2015, 6 (12) : 10532 - 10547
  • [34] MCL-1 expression of non small cell lung cancer is prognostic factor
    Nakano, Takayuki
    Liu, Dage
    Nakashima, Nariyasu
    Yokomise, Hiroyasu
    CANCER SCIENCE, 2018, 109 : 1426 - 1426
  • [35] Mcl-1 expression in human neutrophils: Regulation by cytokines and correlation with cell survival
    Moulding, DA
    Quayle, JA
    Hart, CA
    Edwards, SW
    BLOOD, 1998, 92 (07) : 2495 - 2502
  • [36] Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML):: evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides
    Aichberger, KJ
    Mayerhofer, M
    Krauth, MT
    Skvara, H
    Florian, S
    Sonneck, K
    Akgul, C
    Derdak, S
    Pickl, WF
    Wacheck, V
    Selzer, E
    Monia, BP
    Moriggl, R
    Valent, P
    Sillaber, C
    BLOOD, 2005, 105 (08) : 3303 - 3311
  • [37] Peptide and Small Molecule Inhibitors Targeting Myeloid Cell Leukemia 1 (Mcl-1) as Novel Antitumor Agents
    Lu, Xing
    Liang, Hong
    Orvig, Chris
    Chen, Zhen-Feng
    CURRENT MOLECULAR MEDICINE, 2021, 21 (05) : 426 - 439
  • [38] In silico approaches to identify novel myeloid cell leukemia-1 (Mcl-1) inhibitors for treatment of cancer
    Ren, Ji-Xia
    Li, Cheng-Ping
    Zhou, Xiu-Ling
    Cao, Xue-Song
    Xie, Yong
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2018, 36 (09): : 2424 - 2435
  • [39] Mcl-1, a protein of the Bcl-2 family, protects cell death induced by galig gene expression
    Robinet, P.
    Charpentier, S.
    Dubois, M.
    Mollet, L.
    Normand, T.
    Legrand, A.
    FEBS JOURNAL, 2009, 276 : 266 - 266
  • [40] Inhibiting Mcl-1 with an antisense oligonucleotide induces cell death in acute myeloid leukemia cells
    Carter, Bing Z.
    Mak, Duncan
    Schober, Wendy
    Koller, Erich
    Dean, Nicholas M.
    Marcusson, Eric G.
    Monia, Brett P.
    Andreeff, Michael
    CANCER RESEARCH, 2006, 66 (08)